Bridgefront Capital’s Replimune Group REPL Stock Holding History
Bought
Maintained
Sold
Other funds holding REPL
BBA
FIS
RG
OFM
CCM
Bridgefront Capital's REPL Position: Q1 2024 in Review
Bridgefront Capital sold out of Replimune Group (REPL) in Q1 2024, closing a stake of 10,023 shares — an estimated $84.5K sold.
Bridgefront Capital first reported a position in REPL in Q4 2023 and held it in 1 quarter. The position peaked at $84.5K in Q4 2023. 150 funds tracked by Wall St. Rank hold REPL as of Q1 2024.
- Bridgefront Capital reported no remaining Replimune Group position as of Q1 2024 after selling out during the quarter.
- Bridgefront Capital sold 10,023 Replimune Group shares in Q1 2024, an estimated $84.5K.
- Bridgefront Capital first reported a position in Replimune Group in Q4 2023 and held it in 1 quarter.
- Bridgefront Capital's Replimune Group position peaked at $84.5K in Q4 2023.
- 150 funds tracked by Wall St. Rank held Replimune Group as of Q1 2024.
Based on Bridgefront Capital's 13F filing for Q1 2024, filed 15 May 2024.